Global transmission of oseltamivir-resistant influenza.

  title={Global transmission of oseltamivir-resistant influenza.},
  author={A. R. Moscona},
  journal={The New England journal of medicine},
  volume={360 10},
953 S from one influenza season to the next, we have lost the use of our leading antiviral influenza drug because of resistance. This winter, the circulating strain of seasonal influenza A virus (H1N1) is resistant to the neuraminidase inhibitor osel tamivir. Moreover, rather than emerging under selective pressure of drug use, as many antibiotic-resistant bacteria do and as has been the concern for influenza, this resistant strain seems to be a natural, spontaneously arising variant… CONTINUE READING